Related references
Note: Only part of the references are listed.Chronopharmacological strategies focused on chrono-drug discovery
Shigehiro Ohdo et al.
PHARMACOLOGY & THERAPEUTICS (2019)
UNC569-induced Morphological Changes in Pigment Epithelia and Photoreceptor Cells in the Retina through MerTK Inhibition in Mice
Ayako Sayama et al.
TOXICOLOGIC PATHOLOGY (2018)
Dosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy
Robert Dallmann et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Primary amines protect against retinal degeneration in mouse models of retinopathies
Akiko Maeda et al.
NATURE CHEMICAL BIOLOGY (2012)
Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia
Jing Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Retinol dehydrogenases (RDHs) in the visual cycle
Ryan O. Parker et al.
EXPERIMENTAL EYE RESEARCH (2010)
The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model
So R. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The retinal pigment epithelium in visual function
O Strauss
PHYSIOLOGICAL REVIEWS (2005)
Loss of synchronized retinal phagocytosis and age-related blindness in mice lacking αvβ5 integrin
EE Nandrot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases
DA Thompson et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2003)
Mertk triggers uptake of photoreceptor outer segments during phagocytosis by cultured retinal pigment epithelial cells
W Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat
PM D'Cruz et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
